GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Sopharma AD-Sofia (XBUL:SFA) » Definitions » Net Margin %

Sopharma AD-Sofia (XBUL:SFA) Net Margin %

: 3.50% (As of Dec. 2023)
View and export this data going back to 2000. Start your Free Trial

Net margin is calculated as Net Income divided by its Revenue. Sopharma AD-Sofia's Net Income for the three months ended in Dec. 2023 was лв17 Mil. Sopharma AD-Sofia's Revenue for the three months ended in Dec. 2023 was лв499 Mil. Therefore, Sopharma AD-Sofia's net margin for the quarter that ended in Dec. 2023 was 3.50%.

The historical rank and industry rank for Sopharma AD-Sofia's Net Margin % or its related term are showing as below:

XBUL:SFA' s Net Margin % Range Over the Past 10 Years
Min: 2.07   Med: 4.11   Max: 6.79
Current: 5.08


XBUL:SFA's Net Margin % is ranked better than
76.53% of 98 companies
in the Medical Distribution industry
Industry Median: 1.335 vs XBUL:SFA: 5.08

Sopharma AD-Sofia Net Margin % Historical Data

The historical data trend for Sopharma AD-Sofia's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sopharma AD-Sofia Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Net Margin %
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.79 2.07 5.58 4.28 5.08

Sopharma AD-Sofia Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Net Margin % Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.73 6.90 6.94 3.12 3.50

Competitive Comparison

For the Medical Distribution subindustry, Sopharma AD-Sofia's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sopharma AD-Sofia Net Margin % Distribution

For the Medical Distribution industry and Healthcare sector, Sopharma AD-Sofia's Net Margin % distribution charts can be found below:

* The bar in red indicates where Sopharma AD-Sofia's Net Margin % falls into.



Sopharma AD-Sofia Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Sopharma AD-Sofia's Net Margin for the fiscal year that ended in Dec. 2023 is calculated as

Net Margin=Net Income (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=95.207/1874.422
=5.08 %

Sopharma AD-Sofia's Net Margin for the quarter that ended in Dec. 2023 is calculated as

Net Margin=Net Income (Q: Dec. 2023 )/Revenue (Q: Dec. 2023 )
=17.466/499.44
=3.50 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sopharma AD-Sofia  (XBUL:SFA) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.


Sopharma AD-Sofia Net Margin % Related Terms

Thank you for viewing the detailed overview of Sopharma AD-Sofia's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Sopharma AD-Sofia (XBUL:SFA) Business Description

Traded in Other Exchanges
Address
5 Lachezar Stanchev Street, Sopharma Business Towers, Building A, Floor 11, Sofia, BGR, 1756
Sopharma AD-Sofia is a company engaged in the production of pharmaceutical products. Its principal activities include the production and trade of medicinal substances and finished drug forms; and research and development as well as engineering and implementation activities in the field of medicinal products. It is also focused on the distribution of pharmaceuticals like medical supplies, sanitary materials, vitamins, food supplements, and cosmetics. The company's segments are organized based on the production of finished products which include Tablet dosage forms, Ampoule dosage forms, Medical products, Other forms, and Other revenue. Geographically company operates in Bulgaria and internationally.

Sopharma AD-Sofia (XBUL:SFA) Headlines

No Headlines